Trade Mark Journal No.2026/005 30 January 2026
WO0000001896203 (42)
Office of origin: United States of America
Date of International Registration:26 November 2025
Date of designation in the UK:
26 November 2025

The mark consists of a three dimensional diamond.
International priority date claimed: 31 May 2025
(United States of America)
(99211675)
- Class 42
- Pharmaceutical research and development; research and development services of new pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; research and development services in the field of pharmaceutical preparations; research and development in the field of biotechnology, genetic medicine, gene therapy, biologics, small molecules, DNA, RNA, proteins, vectors and payloads; testing, inspection, research, or development of pharmaceutical preparations for gene therapy.
4D MOLECULAR THERAPEUTICS INC.
Representative: Adam K Sacharoff Much Shelist, PC, 191 N Wacker Drive, Suite 1800, Chicago IL 60606, UNITED STATES OF AMERICA